These two newly minted companies in Silicon Valley are hiring both technical and non-technical roles with their new VC funding! Congratulations!
- Head Office: Mountain View, California
- Funding Details: $5,800,000
- Careers Page: https://www.alivecor.com/careers/
AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder.
AliveCor is pioneering the creation of FDA-cleared ‘machine learning’ techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile ECG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. This simple-to-use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. Kardia Pro is the first AI-enabled platform for doctors to monitor patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia that leads to a five times greater risk of stroke. AliveCor was recognized by Fast Company as one of 2017’s most innovative companies in health (#3). AliveCor is a privately-held company headquartered in Mountain View, California. source
- Head Office: Palo Alto, California
- Funding Details: $1,400,000
Amygdala Neurosciences is developing ANS-6637 a new chemical entity with a novel MOA for treating substance use disorder. Based on a mechanism of action in the brain (published in Nature Medicine) that prevents pathophysiologic dopamine surge without changes to basal dopamine, ANS-6637 has the potential to prevent drug seeking behavior, craving and relapse.
In pre-clinical studies, ALDH2 inhibition reduced self-administration, cue- and drug-primed relapse in nicotine, alcohol, cocaine, heroin, methamphetamine and binge eating models and also demonstrated anxiolytic properties in models of stress. ANS-6637 has completed extensive Phase 1 studies and is ready for Phase 2 efficacy studies.
Their initial development focus is for smoking cessation with parallel development efforts for cocaine, opioid and alcohol use disorders. source
Palo Alto Staffing supports our client with a full workforce management stack including Direct Hire, Temp-to-hire, Consulting, Temporary, and Payrolling (Payroll Service).
We have dedicated processes to support your entire recruitment and contingent worker requirements.